Skip to main content
. 2018 Aug 30;30(1):e1. doi: 10.3802/jgo.2019.30.e1

Fig. 3. (A) LRR, (B) DM, (C) PAR rates in SCC-Ag ≥4 ng/mL and SCC-Ag <4 ng/mL arms.

Fig. 3

DM, distant metastasis; LRR, locoregional recurrence; PAR, para-aortic recurrence; SCC-Ag, squamous-cell carcinoma antigen.